Top Stories
L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM
Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM
Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM
Natco Pharma's Kothur facility gets 8 USFDA observations
Oct 20, 2023
Natco Pharma Limited has announced the completion of an inspection by the United States Food and Drug Administration (USFDA) for its Pharma Division located in Kothur Hyderabad, India.
According to the regulatory filing, the inspection was conducted from October 9, 2023 to October 18, 2023.
“At the end of the inspection, the facility received 8 observations. The company is confident of addressing all the observations within the stipulated time and working with USFDA to close them at the earliest”, Natco Pharma said on Thursday.
On Friday early morning trade, shares of Natco Pharma were trading lower by 0.40% at Rs 830.45 per share on the BSE.
Related News
L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM
Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM
Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM
NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr
4 mins read. August 2, 2024 at 12:33 PM
Download app
Access BlinkX
everywhere
across device
